name,molecular_formula,molecular_weight,smiles,synonyms,cid
PLX3397,C20H15ClF3N5,417.8,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,"['Pexidartinib', '1029044-16-3', 'Pexidartinib (PLX3397)', 'PLX3397', 'PLX-3397', 'Turalio', 'UNII-6783M2LV5X', 'CML-261', '5-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine', 'CHEMBL3813873', '6783M2LV5X', '1029044-16-3 (free base)', '5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine', '5-[(5-Chloro-1h-Pyrrolo[2,3-B]pyridin-3-Yl)methyl]-N-{[6-(Trifluoromethyl)pyridin-3-Yl]methyl}pyridin-2-Amine', '5-({5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyridin-2-amine', 'N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine', 'Pexidartinib [INN]', 'pexidartinibum', 'Pexidartinib [USAN]', 'Pexidartinib(PLX3397)', 'Pexidartinib (USAN/INN)', 'Pexidartinib [USAN:INN]', 'GTPL8710', 'SCHEMBL1267310', 'EX-A589', 'CHEBI:145373', 'HMS3886D19', 'BCP15183', 'PLX 3397', 'BDBM50177716', 'MFCD28900745', 'NSC789300', 'NSC793434', 'NSC800843', 's7818', 'AKOS026750359', 'ZINC115705166', 'CCG-268862', 'DB12978', 'NSC-789300', 'NSC-793434', 'NSC-800843', 'SB19178', 'NCGC00480774-01', 'NCGC00480774-06', '3-Pyridinemethanamine, N-(5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-2-pyridinyl)-6-(trifluoromethyl)-', 'AC-30300', 'AK475466', 'AS-74915', 'DA-48267', 'HY-16749', 'B5854', 'FT-0699505', 'PLX 3397;PLX3397;PL-X3397', 'D11270', 'J-690008', 'Q25100640', '5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridyl]methyl]pyridin-2-amine']",25151352
BLZ945,C20H22N4O3S,398.5,CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)N[C@@H]4CCCC[C@H]4O,"['BLZ945', '953769-46-5', 'BLZ-945', '4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide', 'UNII-7W3V82OQ0P', '7W3V82OQ0P', 'CHEMBL4227505', 'C20H22N4O3S', '4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide', 'BLZ 945', '4-((2-(((1R,2R)-2-Hydroxycyclohexyl)amino)benzo-[d]thiazol-6-yl)oxy)-N-methylpicolinamide', 'MIDODRINEHYDROCHLORIDE', 'GTPL8250', 'SCHEMBL2676695', 'EX-A817', 'SYN1197', '4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide', '3193AH', 'BDBM50460035', 'MFCD28142668', 'NSC758006', 's7725', 'ZINC68203100', 'AKOS025396391', 'CCG-268639', 'CS-3971', 'NSC-758006', 'SB18873', 'NCGC00386432-02', 'NCGC00386432-03', '2-Pyridinecarboxamide, 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)-6-benzothiazolyl)oxy)-N-methyl-', 'AC-32994', 'AS-16330', 'HY-12768', 'QC-11680', 'J3.661.938D', 'Q27075332', '4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzo[d]thiazol-6-yloxy)-N-methylpicolinamide', 'N-Methyl-4-[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]benzothiazole-6-yloxy]pyridine-2-carboxamide']",46184986
GW2580,C20H22N4O3,366.4,COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC,"['GW2580', '870483-87-7', 'GW-2580', 'cFMS Receptor Tyrosine Kinase Inhibitor', 'GW 2580', 'UNII-SRV0JCF9LI', 'GW632580X', '5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine', 'SRV0JCF9LI', '5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]pyrimidine-2,4-diamine', '5-{3-methoxy-4-[(4-methoxybenzyl)oxy]benzyl}pyrimidine-2,4-diamine', '5-(3-METHOXY-4-(4-METHOXYBENZYLOXY)BENZYL)PYRIMIDINE-2,4-DIAMINE', '2,4-Pyrimidinediamine, 5-((3-methoxy-4-((4-methoxyphenyl)methoxy)phenyl)methyl)-', 'CSF-1 Receptor Inhibitor', '5-[3-Methoxy-4-[(4-methoxybenzyl)oxy]benzyl]pyrimidine-2,4-diamine', '2,4-Pyrimidinediamine, 5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-', '5-({3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl}methyl)pyrimidine-2,4-diamine', 'Kinome_3757', '4at5', 'SC-203877', 'cc-705', 'CHEMBL261849', 'GTPL5685', 'SCHEMBL4326587', 'BDBM32362', 'AOB6789', 'DTXSID10236095', 'EX-A579', 'cid_11617559', 'HMS3229E11', 'HMS3303G12', 'HMS3305H21', 'HMS3653B06', 'HMS3673K11', 'BCP06918', '5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)-pyrimidine-2,4-diamine', 'MFCD12024701', 'NSC756292', 's8042', 'ZINC13985942', 'AKOS022179064', 'AM81255', 'CCG-206754', 'CS-3490', 'GW 2380', 'NSC-756292', 'SB19390', 'NCGC00242051-01', 'NCGC00242051-11', 'AC-32806', 'AK-43753', 'AS-55846', 'HY-10917', 'GW-2580 (GW2580)', 'FT-0700386', 'G-255', 'G0504', 'SW212674-2', 'Y0454', 'A11959', 'S-7799', 'AB01092267-01', 'Q27077940', 'cFMS Receptor Tyrosine Kinase Inhibitor - CAS 870483-87-7', '[2-amino-5-(3-methoxy-4-p-anisyloxy-benzyl)pyrimidin-4-yl]amine', '5-[3-Methoxy-4-(4-methoxybenzyloxy)-benzyl]pyrimidine-2,4-diamine', '5-[[3-Methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]-2,4-pyrimidinediamine', '5-[[3-methoxy-4-[(4-methoxyphenyl)methoxy]phenyl]methyl]pyrimidine-2,4-diamine.', 'MUJ']",11617559
